Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

CoreAge Rx vs Bliv

Two GLP-1 providers, one scoreboard. We put CoreAge Rx and Bliv head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 1 · Grade A

CoreAge Rx

Visit CoreAge Rx Full brief →
vs
No. 306 · Grade C

Bliv

Visit Bliv Full brief →

FDA warning letter, February 2026 — issued to Bliv Wellness LLC dba Bliv. See the FDA's warning letter database.

The verdict

CoreAge Rx takes this head-to-head.

CoreAge Rx scores 94 to 63 on our six-factor Brief Score — CoreAge publishes different starting offers across its pages; the advertised annual rates require a full year paid upfront.

That doesn't make Bliv a bad call — it's best for readers who can obtain the full selected-plan quote and distinguish subscription, clinical evaluation and pharmacy charges. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both providers scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
97
48
Supply Reliability
95
74
Transparency
90
72
Access Breadth
93
50
Clinical Oversight
92
82
Track Record
88
51
CoreAge RxBrief Score 94 · 63Bliv

Price, coverage & the tracker

CoreAge RxBliv
Brief Score94/100 (A)63/100 (C)
Semaglutide

From $79/mo

Annual offer: 12 months paid upfront, from $948.

Main site: from $99/mo; confirm the selected offer.

Full price details

From $79/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($948 at that starting rate); main product page separately advertises from $99/mo

As low as $116/month

Based on plan structure and eligibility; full upfront charge, dose and supply unconfirmed. Generic $58/month promotion is not a complete semaglutide quote.

Medication charged after approval; refund cutoff is prescription transmission. Subscription cancellation does not cancel a pending prescription.

Full price details

Compounded semaglutide offered; complete current selected-plan quote unknown; public page lists as low as $116/month based on plan structure and eligibility, alongside a generic $58/month promotion

Tirzepatide

From $129/mo

Annual offer: 12 months paid upfront, from $1,548.

Main site: from $149/mo; confirm the selected offer.

Full price details

From $129/mo on the annual-plan landing offer, based on a 12-month plan paid in full ($1,548 at that starting rate); main product page separately advertises from $149/mo

As low as $199/month

Based on plan structure and eligibility; selected total and supply unconfirmed. Financing installment is not the medication price.

Evaluation fee becomes final after evaluation and offered treatment; paid subscription fees ordinarily are not prorated. Medication has its own cutoff.

Full price details

Compounded tirzepatide offered; complete current selected-plan quote unknown; public page lists as low as $199/month based on plan structure and eligibility, alongside a generic $58/month promotion

CoverageUS only; restrictions by state, confirmed at intakeU.S. care requires a clinician licensed for the patient’s physical location; exact treatment-specific coverage requires confirmation
Brand-name accessNot confirmedCurrent branded GLP-1 prescribing availability was not established on the reviewed pages.
Oral / sublingualInjection onlyUnconfirmed
On the trackerStableprice stableNewnew to the tracker, no prior reading

CoreAge Rx: The checked annual-plan offer starts at $79/$129 per month on annual prepay; the main product pages still show $99/$149. Confirm the selected offer.

Bliv: As-low-as figures depend on plan and eligibility; full selected payment unconfirmed. Current terms separate subscription, evaluation and medication charges; pharmacy transmission ends ordinary medication refunds.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.